Small Cell Neuroendocrine Carcinoma — Trials

Small Cell Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,165 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 396
Recruiting: 209
Ph III recruiting: 27
Growth YoY: +1%
Industry share: 42%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (167)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04165330	Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors	active not recruiting	Phase 1 / Phase 2	56	Sarcoma Oncology Research Center, LLCOTHER	1	Feb 24, 2025	clinicaltrials
NCT05879068	A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC	active not recruiting	Phase 2	99	Biotheus Inc.INDUSTRY	1	Dec 18, 2024	clinicaltrials